PYRIMETHAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pyrimethamine, and what generic alternatives are available?
Pyrimethamine is a drug marketed by Alvogen, Aurobindo Pharma Ltd, Cerovene Inc, and Teva Pharms. and is included in four NDAs.
The generic ingredient in PYRIMETHAMINE is pyrimethamine. There are three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pyrimethamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pyrimethamine
A generic version of PYRIMETHAMINE was approved as pyrimethamine by CEROVENE INC on February 28th, 2020.
Summary for PYRIMETHAMINE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 128 |
Clinical Trials: | 217 |
Patent Applications: | 4,745 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PYRIMETHAMINE |
What excipients (inactive ingredients) are in PYRIMETHAMINE? | PYRIMETHAMINE excipients list |
DailyMed Link: | PYRIMETHAMINE at DailyMed |
Recent Clinical Trials for PYRIMETHAMINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Washington University School of Medicine | Early Phase 1 |
Menzies School of Health Research | Phase 3 |
Curtin University | Phase 3 |
Pharmacology for PYRIMETHAMINE
Drug Class | Dihydrofolate Reductase Inhibitor Antimalarial |
Mechanism of Action | Dihydrofolate Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for PYRIMETHAMINE
Anatomical Therapeutic Chemical (ATC) Classes for PYRIMETHAMINE
US Patents and Regulatory Information for PYRIMETHAMINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alvogen | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 211271-001 | Jul 27, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Teva Pharms | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 215506-001 | Aug 13, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Aurobindo Pharma Ltd | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 216983-001 | Oct 25, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Cerovene Inc | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 207127-001 | Feb 28, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |